Reviva Pharmaceuticals Holdings Inc.

+0.01 (+0.29%)
Earnings Announcements

Reviva Pharmaceuticals Holdings Inc Reports 2020 Financial Results

Published: 03/22/2021 12:32 GMT
Reviva Pharmaceuticals Holdings Inc. (RVPH) - Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corporate Update.
Reviva Pharmaceuticals Holdings, Inc. - Plans to Initiate a Pivotal Phase 3 Trial in Schizophrenia in Mid-2021, Assuming Fundraising Goals Achieved.
Reviva Pharmaceuticals .
- Believes Cash and Cash Equivalents at Dec.
31, 2020 Will Be Sufficient to Cover General Operating Expenses Through 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33

More details on our Analysts Page.